Benjamin Bertrand

Benjamin Bertrand is the CEO of Cardiawave, a biotechnology company that produces therapeutic messenger RNA for gene therapy, cell therapy and vaccines. Benjamin is also a board member and co-founder of Eukarÿs SAS.

Bertrand has been involved in the development and production of therapeutic messenger RNA since May 2009. In this role, they have been responsible for the company's strategy, business development, intellectual property, and financial planning. Benjamin has also represented the company at tradeshows, conferences, and conventions.

Bertrand has been instrumental in the success of Cardiawave, helping to position the company as a leader in its field. Benjamin has also been recognized for their work with several awards, including the Tremplin Entreprises Prize, the Techinnov Prize, and the Masters of Business Creation in France.

Benjamin Bertrand has a Master in Management from ESCP Business School and a high school diploma in sciences from Lakanal in Sceaux.

Prathamesh Joshi - Test & Validation Engineer, Mathieu Rémond - Preclinical Project Manager, and Edgar Tieo - Integration & Validation Engineer report to Benjamin Bertrand.